Efficacy of subantimicrobial dose of doxycycline in the treatment of acne of moderate severity: a review of international studie

Cover Page

Cite item

Abstract

The article analyzes the recent data concerning the new trends in the treatment of acne vulgaris of moderate severity using tetracyclines. Low-dose regimen of doxycycline is highly effective against inflammatory and noninflammatory lesions in patients with moderate acne on the face with a minority of side effects.

About the authors

A. A. Khryanin

Novosibirsk State Medical University

Author for correspondence.
Email: khryanin@mail.ru
Russian Federation

O. V. Reshetnikov

Federal State Budgetary Institution of Internal and Preventive Medicine Siberian Branch under the Russian Academy of Medical Sciences

Email: noemail@neicon.ru
Russian Federation

References

  1. Sykes L.S., Webster G.F. Acne. A review of optimum treatment. Drugs 1994; 48: 59-70.
  2. Meynadier J., Alirezai M. Systemic antibiotics for acne. Dermatology 1998; 33б (16): 1156-1162.
  3. Jugeau S., Tenaud I., Knol A.C. Induction of tolllike receptors by Propionibacterium acnes. Br J Dermatol 2005; 153: 1105-1113.
  4. Kozlovskaya V.V., Khaykova E.A. Terapiya akne sredney stepeni tyazhesti s ispol'zovaniem nizkikh doz doksitsiklina (Yunidoksa Solyutab). Meditsinskie novosti 2011; 2: 72-75.
  5. Hayashi N., Akamatsu H., Kawashima M. Acne Study Group. establishment of grading criteria for acne severity. J Dermatol 2008; 35 (5): 255-260.
  6. Kotova N.V., Suvorova K.N. Yunosheskie akne. Moskva: NPF «Nov'» 2002; 54.
  7. Estery N.B., Koransky J.S., Furey N.I., Trevisan M. Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy. Arch Dermatol 1984; 120: 1308-1313.
  8. Cunliffe W.J. Evolution of strategy for the treatment of acne. J Am Acad Dermatol 1987; 16: 591-599.
  9. Greenfood R., Burke B., Cunliffe W.J. Evolution of a therapeutic strategy for the treatment of acne vulgaris with conventional therapy. Br J Dermatol 1986; 114: 353-358.
  10. Lever L., Marks R. Current views on the aetiology, pathogenesis and treatment of acne vulgaris. Drugs 1990; 39 (5): 681-692.
  11. Araviyskaya Ye.R., Sokolovsky Ye.V. Systemic antibiotics therapy of acne: certain controversies.Vestnik Dermatologii i Venerologii 2013; 6: 117-121.
  12. Zaenglein A.L., Thiboutot D.M. Expert Committee Recommendations for Acne Management. Pediatrics 2006; 118: 1188-1199.
  13. Thiboutot D., Gollnick H.P., Bettoli V. et al. New insights into the management of acne: An update from the Global Alliance to improve outcomes in acne group. J Am Acad Dermatol 2009; 60 (5 Suppl): S1-S50.
  14. Nast A., Dreno B., Bettoli V. et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 2012, 26 (Suppl 1): 1-29.
  15. Akne / Pod red. Kubanovoy A. Moskva: DEKS-Press 2010; 28. [Акне / Под ред. А.А. Кубановой. Москва: ДЭКС-Пресс 2010; 28.]
  16. Engebretson S.P., Hey-Hadavi J. Sub-antimicrobial doxycycline for periodontitis reduces hemoglobin A1c in subjects with type 2 diabetes: a pilot study. Pharmacol Res 2011; 64 (6): 624-629.
  17. Gu Y., Walker C., Ryan M.E. et al. Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicine. J Oral Microbiol 2012; 4: 10.3402/jom.v4i0.19227.
  18. Golub L.M., Greenwald R.A., Thompson R.W. Tetracycline use and risk of acute myocardial infarction. JAMA 1999; 282: 1997-1998.
  19. Toossi P., Farshchian M., Malekzad F. et al. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne. J Drugs Dermatol 2008; 7 (12): 1149-1152.
  20. Parish L.C., Parish J.L., Routh H.B., Witkowski J.A. The treatment of acne vulgaris with low dosage doxycycline. Acta Dermatovenerol Croat 2005; 13 (3): 156-159.
  21. Maleszka R., Turek-Urasinska K., Oremus M. et al. Pulsed azithromycin treatment is as effective and safe as 2-week-longer daily doxycycline treatment of acne vulgaris: a randomized, double-blind, noninferiority study. Skinmed 2011; 9 (2): 86-94.
  22. Babaeinejad S., Khodaeiani E., Fouladi R.F. Comparison of therapeutic effects of oral doxycycline and azithromycin in patients with moderate acne vulgaris: what is the role of age? J Dermatolog Treat 2011; 22 (4): 206-210.
  23. Skidmore R., Kovach R., Walker C. et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 2003; 139 (4): 459-464.
  24. Nast A., Dreno B., Bettoli V. et al. European evidence-based (S3) guidelines for the treatment of acne. JEADV 2012, 26 (Suppl 1): 1-29.
  25. Хрянин А.А. Комплексная патогенетическая терапия акне. Клиничегаий случай. Consilium Medicum 2014; 1: 18-19.
  26. Kleine M.W. Introduction to oral enzyme therapy. Int J Immunotherapy 1997; 13: 59-65.

Copyright (c) 2014 Khryanin A.A., Reshetnikov O.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies